Drug class

Radiopharmaceuticals clinical trials

A class of medicines: the studies that test any of its 334 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it: 1,299
open now: 297
in phase 3: 163
first study started: 1993

Keep track of what changes. Save the radiopharmaceuticals studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Gallium 68 PSMA-11: 63
Lutetium (¹⁷⁷Lu) vipivotide tetraxetan: 47
Lutetium Lu 177 dotatate: 46
Ibritumomab tiuxetan: 44
Fluorodeoxyglucose F18: 39
Florbetapir: 37
Fluciclovine F-18: 36
Radium Ra 223 dichloride: 35
Tipranavir: 34
Flortaucipir: 31
Piflufolastat: 30
Gallium Ga 68 dotatate: 24
68Ga-FAPI: 23
Tositumomab I-131: 23
Hyperpolarized Carbon C 13 (1-13C) Pyruvate: 22
Technetium tc-99m tilmanocept: 21
Sodium phosphate: 20
Flotufolastat F 18: 17
Alovudine: 16
3-Iodobenzylguanidine: 16
68Ga-pentixafor: 15
Florbetaben f-18: 15
Fluorodopa F 18: 15
Selenomethionine: 14
Pittsburgh compound B: 13
Florbenazine F 18: 11
Florilglutamic acid f-18: 10
Fluorocholine: 10
Flutemetamol: 10
Fluoromisonidazole: 10
Rm-2 ga-68: 10
CLR1404: 9
Fluoroestradiol f-18: 9
Carbon-11 acetate: 9
Florzolotau F-18: 9
Iobenguane I-123: 8
177Lu-octreotide, DOTA(0)-Tyr(3)-: 7
FAPI-46: 7
Lutetium Lu 177 Zadavotide Guraxetan: 7
Zirconium Zr 89 Girentuximab: 7

And 294 more, each tested in fewer studies.

Studies by the year they started

1,283 studies that test it; most in 2021 (97); 3 more planned to start later

Studies that test Radiopharmaceuticals, by start year
Year	Studies
1993	1
1994	2
1995	1
1996	2
1997	1
1998	4
1999	6
2000	4
2001	4
2002	9
2003	19
2004	15
2005	25
2006	20
2007	39
2008	39
2009	30
2010	32
2011	28
2012	49
2013	47
2014	46
2015	56
2016	53
2017	65
2018	60
2019	68
2020	78
2021	97
2022	85
2023	75
2024	76
2025	86
2026	61

By phase

A phase 1/2 study counts in both.

Early Phase 1: 158
Phase 1: 436
Phase 2: 527
Phase 3: 163
Phase 4: 43
No phase: 109

What it is tested for

Each study’s main condition, where its own words name it.

Prostatic Neoplasms: 230
Alzheimer Disease: 80
Breast Neoplasms: 43
Neuroendocrine Tumors: 40
Neoplasms: 38
Lymphoma, Non-Hodgkin: 33
Carcinoma, Renal Cell: 28
Carcinoma: 24
Glioblastoma: 23
Multiple Myeloma: 21
HIV Infections: 21
Neuroblastoma: 20

Who runs them

Industry 420 · Other 879

Peking Union Medical College Hospital (55) · Avid Radiopharmaceuticals (49) · M.D. Anderson Cancer Center (36) · Mayo Clinic (33) · Bayer (30) · Boehringer Ingelheim (29) · National Cancer Institute (NCI) (23) · Memorial Sloan Kettering Cancer Center (21)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 1,299

See all 1,299 studies that test one of the radiopharmaceuticals →

Codes

What other systems call Radiopharmaceuticals · ClinicalTrials.gg INT008670

MeSH (NLM) D019275RadiopharmaceuticalsOne source ClinicalTrials.gov

System	Code	Name there	Checked by
MeSH (NLM)	D019275	Radiopharmaceuticals	One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.